TNF-α antagonists, including anti-TNF receptor antibodies and anti-IL-6 receptor antibodies, are currently used to inhibit the action of each proinflammatory cytokine for the treatment of RA and Crohn’s disease [35,36]. Here, TNF is linked to rheumatoid arthritis.